Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Lorusso

Showing results (91-100 of 171) with videos related to

Pageof 18
Sort By:
Haematologica|July 1, 1993
Bulky mediastinal Hodgkin's disease: results of a combined modality approach (ABVD/MOPP alternating chemotherapy plus radiation therapy)M De Lena, P Ditonno, V Lorusso, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1989
Comparison of CHOP-B vs CEOP-B in 'poor prognosis' non-Hodgkin's lymphomas. A randomized trialM De Lena, E Maiello, V Lorusso, et al.
Molecular Imaging and Biology|April 16, 2015
In Vivo MR Imaging of Fibrin in a Neuroblastoma Tumor Model by Means of a Targeting Gd-Containing PeptideL Chaabane, L Tei, L Miragoli, et al.
The Journal of Biological Chemistry|April 5, 2000
cAMP-dependent phosphorylation of the nuclear encoded 18-kDa (IP) subunit of respiratory complex I and activation of the complex in serum-starved mouse fibroblast culturesS Scacco, R Vergari, R C Scarpulla, et al.
Magnetic Resonance in Medicine|May 21, 2005
Multiexponential T2-relaxation analysis in cerebrally damaged rats in the absence and presence of a gadolinium contrast agentA Lascialfari, I Zucca, M Asdente, et al.
Acta Radiologica. Supplementum|January 1, 1997
Hepatocyte-directed MR contrast agents. Can we take advantage of bile acids?P L Anelli, L Calabi, C de Haën, et al.
Il Giornale Di Chirurgia|February 18, 2019
Amyand's hernia: role of CT for a correct diagnosisA Drago, M Carbone, V Lorusso, et al.
Investigative Radiology|December 24, 1997
Gadolinium chelates with weak binding to serum proteins. A new class of high-efficiency, general purpose contrast agents for magnetic resonance imagingF M Cavagna, F Maggioni, P M Castelli, et al.
Journal of Chemotherapy (Florence, Italy)|January 29, 2005
Radiofrequency thermal ablation of 69 lung neoplasmsC Gadaleta, A Catino, G Ranieri, et al.
Tumori|June 30, 1993
M-VECA (methotrexate, vinblastine, epidoxorubicin and carboplatin) in the treatment of advanced urothelial carcinomaV Lorusso, F Berardi, M Brandi, et al.
Pageof 18

Showing results (91-100 of 171) with videos related to

Sort By:
Pageof 18
Haematologica|July 1, 1993
Bulky mediastinal Hodgkin's disease: results of a combined modality approach (ABVD/MOPP alternating chemotherapy plus radiation therapy)M De Lena, P Ditonno, V Lorusso, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1989
Comparison of CHOP-B vs CEOP-B in 'poor prognosis' non-Hodgkin's lymphomas. A randomized trialM De Lena, E Maiello, V Lorusso, et al.
Molecular Imaging and Biology|April 16, 2015
In Vivo MR Imaging of Fibrin in a Neuroblastoma Tumor Model by Means of a Targeting Gd-Containing PeptideL Chaabane, L Tei, L Miragoli, et al.
The Journal of Biological Chemistry|April 5, 2000
cAMP-dependent phosphorylation of the nuclear encoded 18-kDa (IP) subunit of respiratory complex I and activation of the complex in serum-starved mouse fibroblast culturesS Scacco, R Vergari, R C Scarpulla, et al.
Magnetic Resonance in Medicine|May 21, 2005
Multiexponential T2-relaxation analysis in cerebrally damaged rats in the absence and presence of a gadolinium contrast agentA Lascialfari, I Zucca, M Asdente, et al.
Acta Radiologica. Supplementum|January 1, 1997
Hepatocyte-directed MR contrast agents. Can we take advantage of bile acids?P L Anelli, L Calabi, C de Haën, et al.
Il Giornale Di Chirurgia|February 18, 2019
Amyand's hernia: role of CT for a correct diagnosisA Drago, M Carbone, V Lorusso, et al.
Investigative Radiology|December 24, 1997
Gadolinium chelates with weak binding to serum proteins. A new class of high-efficiency, general purpose contrast agents for magnetic resonance imagingF M Cavagna, F Maggioni, P M Castelli, et al.
Journal of Chemotherapy (Florence, Italy)|January 29, 2005
Radiofrequency thermal ablation of 69 lung neoplasmsC Gadaleta, A Catino, G Ranieri, et al.
Tumori|June 30, 1993
M-VECA (methotrexate, vinblastine, epidoxorubicin and carboplatin) in the treatment of advanced urothelial carcinomaV Lorusso, F Berardi, M Brandi, et al.
Pageof 18